202 related articles for article (PubMed ID: 16418318)
1. Inhibition of LINE-1 expression in the heart decreases ischemic damage by activation of Akt/PKB signaling.
Lucchinetti E; Feng J; Silva Rd; Tolstonog GV; Schaub MC; Schumann GG; Zaugg M
Physiol Genomics; 2006 Apr; 25(2):314-24. PubMed ID: 16418318
[TBL] [Abstract][Full Text] [Related]
2. Ischemic postconditioning protects remodeled myocardium via the PI3K-PKB/Akt reperfusion injury salvage kinase pathway.
Zhu M; Feng J; Lucchinetti E; Fischer G; Xu L; Pedrazzini T; Schaub MC; Zaugg M
Cardiovasc Res; 2006 Oct; 72(1):152-62. PubMed ID: 16901477
[TBL] [Abstract][Full Text] [Related]
3. Metformin protects the ischemic heart by the Akt-mediated inhibition of mitochondrial permeability transition pore opening.
Bhamra GS; Hausenloy DJ; Davidson SM; Carr RD; Paiva M; Wynne AM; Mocanu MM; Yellon DM
Basic Res Cardiol; 2008 May; 103(3):274-84. PubMed ID: 18080084
[TBL] [Abstract][Full Text] [Related]
4. Postconditioning: a form of "modified reperfusion" protects the myocardium by activating the phosphatidylinositol 3-kinase-Akt pathway.
Tsang A; Hausenloy DJ; Mocanu MM; Yellon DM
Circ Res; 2004 Aug; 95(3):230-2. PubMed ID: 15242972
[TBL] [Abstract][Full Text] [Related]
5. Preconditioning by isoflurane retains its protection against ischemia-reperfusion injury in postinfarct remodeled rat hearts.
Lucchinetti E; Jamnicki M; Fischer G; Zaugg M
Anesth Analg; 2008 Jan; 106(1):17-23, table of contents. PubMed ID: 18165546
[TBL] [Abstract][Full Text] [Related]
6. Lipopolysaccharide-induced myocardial protection against ischaemia/reperfusion injury is mediated through a PI3K/Akt-dependent mechanism.
Ha T; Hua F; Liu X; Ma J; McMullen JR; Shioi T; Izumo S; Kelley J; Gao X; Browder W; Williams DL; Kao RL; Li C
Cardiovasc Res; 2008 Jun; 78(3):546-53. PubMed ID: 18267957
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of contractile activity during postconditioning enhances cardioprotection by restoring sarcolemmal dystrophin through phosphatidylinositol 3-kinase.
Moriguchi A; Otani H; Yoshioka K; Shimazu T; Fujita M; Okazaki T; Sato D; Kyoi S; Iwasaka T
Circ J; 2010 Nov; 74(11):2393-402. PubMed ID: 20877127
[TBL] [Abstract][Full Text] [Related]
8. Critical role of PI3-kinase/Akt activation in the PARP inhibitor induced heart function recovery during ischemia-reperfusion.
Kovacs K; Toth A; Deres P; Kalai T; Hideg K; Gallyas F; Sumegi B
Biochem Pharmacol; 2006 Feb; 71(4):441-52. PubMed ID: 16337154
[TBL] [Abstract][Full Text] [Related]
9. Cordycepin, 3'-deoxyadenosine, prevents rat hearts from ischemia/reperfusion injury via activation of Akt/GSK-3β/p70S6K signaling pathway and HO-1 expression.
Park ES; Kang DH; Yang MK; Kang JC; Jang YC; Park JS; Kim SK; Shin HS
Cardiovasc Toxicol; 2014 Mar; 14(1):1-9. PubMed ID: 24178833
[TBL] [Abstract][Full Text] [Related]
10. Kinases and phosphatases in ischaemic preconditioning: a re-evaluation.
Fan WJ; van Vuuren D; Genade S; Lochner A
Basic Res Cardiol; 2010 Jul; 105(4):495-511. PubMed ID: 20127248
[TBL] [Abstract][Full Text] [Related]
11. Delayed remote ischemic preconditioning produces an additive cardioprotection to sevoflurane postconditioning through an enhanced heme oxygenase 1 level partly via nuclear factor erythroid 2-related factor 2 nuclear translocation.
Zhou C; Li H; Yao Y; Li L
J Cardiovasc Pharmacol Ther; 2014 Nov; 19(6):558-66. PubMed ID: 24651515
[TBL] [Abstract][Full Text] [Related]
12. Role of phosphoinositide 3-kinase IA (PI3K-IA) activation in cardioprotection induced by ouabain preconditioning.
Duan Q; Madan ND; Wu J; Kalisz J; Doshi KY; Haldar SM; Liu L; Pierre SV
J Mol Cell Cardiol; 2015 Mar; 80():114-25. PubMed ID: 25575882
[TBL] [Abstract][Full Text] [Related]
13. Remifentanil Preconditioning Reduces Postischemic Myocardial Infarction and Improves Left Ventricular Performance via Activation of the Janus Activated Kinase-2/Signal Transducers and Activators of Transcription-3 Signal Pathway and Subsequent Inhibition of Glycogen Synthase Kinase-3β in Rats.
Qiao S; Mao X; Wang Y; Lei S; Liu Y; Wang T; Wong GT; Cheung CW; Xia Z; Irwin MG
Crit Care Med; 2016 Mar; 44(3):e131-45. PubMed ID: 26468894
[TBL] [Abstract][Full Text] [Related]
14. Differential role of PI3K/Akt pathway in the infarct size limitation and antiarrhythmic protection in the rat heart.
Ravingerová T; Matejíková J; Neckár J; Andelová E; Kolár F
Mol Cell Biochem; 2007 Mar; 297(1-2):111-20. PubMed ID: 17016676
[TBL] [Abstract][Full Text] [Related]
15. SCH 79797, a selective PAR1 antagonist, limits myocardial ischemia/reperfusion injury in rat hearts.
Strande JL; Hsu A; Su J; Fu X; Gross GJ; Baker JE
Basic Res Cardiol; 2007 Jul; 102(4):350-8. PubMed ID: 17468933
[TBL] [Abstract][Full Text] [Related]
16. Reduced susceptibility to ischemia-induced arrhythmias in the preconditioned rat heart is independent of PI3-kinase/Akt.
Ravingerova T; Matejikova J; Pancza D; Kolar F
Physiol Res; 2009; 58(3):443-447. PubMed ID: 19627174
[TBL] [Abstract][Full Text] [Related]
17. Activation of RISK and SAFE pathways is not involved in the effects of Cx43 deficiency on tolerance to ischemia-reperfusion injury and preconditioning protection.
Sánchez JA; Rodríguez-Sinovas A; Barba I; Miró-Casas E; Fernández-Sanz C; Ruiz-Meana M; Alburquerque-Béjar JJ; García-Dorado D
Basic Res Cardiol; 2013 May; 108(3):351. PubMed ID: 23595215
[TBL] [Abstract][Full Text] [Related]
18. Ischemic preconditioning protects by activating prosurvival kinases at reperfusion.
Hausenloy DJ; Tsang A; Mocanu MM; Yellon DM
Am J Physiol Heart Circ Physiol; 2005 Feb; 288(2):H971-6. PubMed ID: 15358610
[TBL] [Abstract][Full Text] [Related]
19. Myocardial protection by insulin at reperfusion requires early administration and is mediated via Akt and p70s6 kinase cell-survival signaling.
Jonassen AK; Sack MN; Mjøs OD; Yellon DM
Circ Res; 2001 Dec; 89(12):1191-8. PubMed ID: 11739285
[TBL] [Abstract][Full Text] [Related]
20. Protective effect of urantide against ischemia-reperfusion injury via protein kinase C and phosphtidylinositol 3'-kinase - Akt pathway.
Zhang JY; Chen ZW; Yao H
Can J Physiol Pharmacol; 2012 May; 90(5):637-45. PubMed ID: 22537485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
